Phenotypes associated with this allele
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm1(CARD14*)Ribt mutation
(0 available);
any
Gt(ROSA)26Sor mutation
(944 available)
Tg(KRT5-cre)5132Jlj mutation
(1 available)
|
|
|
mortality/aging
|
• mice delivered by Caesarian section do not survive beyond 24 hours after birth
|
integument
N |
• mice exhibit normal epidermal skin barrier function
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm1(CARD14*)Ribt mutation
(0 available);
any
Gt(ROSA)26Sor mutation
(944 available)
Malt1tm1c(EUCOMM)Hmgu mutation
(0 available);
any
Malt1 mutation
(33 available)
Tg(KRT5-cre)5132Jlj mutation
(1 available)
|
|
|
mortality/aging
N |
• mice exhibit normal postnatal survival
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm1(CARD14*)Ribt mutation
(0 available);
any
Gt(ROSA)26Sor mutation
(944 available)
Tg(KRT14-cre/ERT)20Efu mutation
(3 available)
|
|
|
mortality/aging
|
• in tamoxifen-treated mice
|
integument
|
• in the basal layer of ear skin of tamoxifen-treated mice
|
|
• reminiscent of Munros abscesses in the stratum corneum in tamoxifen-treated mice
|
|
• in tamoxifen-treated mice
|
|
• in tamoxifen-treated mice
|
|
• in tamoxifen-treated mice
|
|
• in tamoxifen-treated mice
|
|
• from 6 weeks on, mice exhibit mild ear thickening unlike control mice
• tamoxifen-treated mice exhibit increased progressive ear swelling with ears becoming scaly and red unlike control mice
|
immune system
|
• in the ear of tamoxifen-treated mice
|
|
• in the ear of tamoxifen-treated mice
|
|
• reminiscent of Munros abscesses in the stratum corneum in tamoxifen-treated mice
|
growth/size/body
|
• in tamoxifen-treated mice
|
homeostasis/metabolism
cellular
|
• in the basal layer of ear skin of tamoxifen-treated mice
|
hematopoietic system
|
• in the ear of tamoxifen-treated mice
|
|
• in the ear of tamoxifen-treated mice
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm1(CARD14*)Ribt mutation
(0 available);
any
Gt(ROSA)26Sor mutation
(944 available)
Malt1tm1c(EUCOMM)Hmgu mutation
(0 available);
any
Malt1 mutation
(33 available)
Tg(KRT14-cre/ERT)20Efu mutation
(3 available)
|
|
|
integument
|
• in tamoxifen-treated mice that is not as severe as in mice with wild-type Matl1
|
|
• in tamoxifen-treated mice that is not as severe as in mice with wild-type Matl1
|
|
• from 6 weeks on, mice exhibit mild ear thickening unlike control mice
• tamoxifen-treated mice exhibit increased ear swelling that is not as severe as in mice with wild-type Matl1
|
immune system
|
• in tamoxifen-treated mice that is not as severe as in mice with wild-type Matl1
|
|
• in tamoxifen-treated mice that is not as severe as in mice with wild-type Matl1
|
|
• in tamoxifen-treated mice that is not as severe as in mice with wild-type Matl1
|
growth/size/body
|
• in tamoxifen-treated that is not as severe as in mice with wild-type Matl1
|
hematopoietic system
|
• in tamoxifen-treated mice that is not as severe as in mice with wild-type Matl1
|
|
• in tamoxifen-treated mice that is not as severe as in mice with wild-type Matl1
|